Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy.

Mazouni, Chafika

Kinetics of serum HER-2/neu changes in patients with HER-2-positive primary breast cancer after initiation of primary chemotherapy. [electronic resource] - Cancer Feb 2007 - 496-501 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0008-543X

10.1002/cncr.22418 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor--blood
Breast Neoplasms--blood
Carcinoma, Ductal, Breast--blood
Carcinoma, Lobular--blood
Cyclophosphamide--administration & dosage
Epirubicin--administration & dosage
Female
Fluorouracil--administration & dosage
Humans
Kinetics
Middle Aged
Neoadjuvant Therapy
Prognosis
Prospective Studies
Receptor, ErbB-2--blood
Trastuzumab